LSBio
OPRK1 / Kappa Opioid Receptor Antibody (310-390 aa)

Western blot of Phospho-KOR-1 (S369) antibody

OPRK1 / Kappa Opioid Receptor Antibody (310-390 aa)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Western Blot
Reactivity:Mouse, Rat
Format:Liquid
See all Mouse OPRK1 / Kappa Opioid Receptor antibodies →
$301.00each
Catalog Number: LS-C380901-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
Kappa Opioid Receptor antibody LS-C380901 is an unconjugated rabbit polyclonal antibody to Kappa Opioid Receptor (OPRK1) (310-390 aa) from mouse. It is reactive with mouse and rat. Validated for ELISA, IHC and WB. Cited in 1 publication.
Application
ELISA, IHC, WB
Reactivity
Ms, Rt
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
Kappa-type opioid receptor | Opiate receptor, kappa-1 | K-OR-1 | KOR | Opioid receptor, kappa 1 | OPRK | Ork1 | Kappa opioid receptor | KOR-1 | Opioid receptor kappa | OPRK1
Recommended Dilution: ELISA
1:10000
Recommended Dilution: IHC
1:100 - 1:300
Recommended Dilution: WB
1:500 - 1:2000
UniProt Number
P41145
SwissProt
P41145

Target

Target
Mouse OPRK1 / Kappa Opioid Receptor
Antigen Species
Mouse
Epitope
Phospho-KOR-1 (S369) Polyclonal Antibody detects endogenous levels of KOR-1 protein only when phosphorylated at S369.
Gene Name
OPRK1

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Isotype
IgG

Immunogen

Immunogen
Synthesized peptide derived from human KOR-1 around the phosphorylation site of S369.
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. Xie JY, De Felice M, Kopruszinski CM, Eyde N, LaVigne J, Remeniuk B, Hernandez P, Yue X, Goshima N, Ossipov M, King T, Streicher JM, Navratilova E, Dodick D, Rosen H, Roberts E, Porreca F. Cephalalgia. 2017 July;37:780-794. PubMed: 28376659 PMC: PMC6085081

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.